RIPK3 and breast cancer: Many researchers are also exploring more diverse strategic approaches to induce necroptosis to treat BC, such as the addition of hypomethylating agents to induce the expression of RIP3 [147] and metal analogs to induce necroptosis to overcome drug resistance in BC [153].